ConductScience.org, home

Paper24700706

Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.

Morice MC and 14 others. Circulation, 2014. Cited by 397 papers, by iCite.

Cite this record

ConductScience Library. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Papers, record 24700706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24700706

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
PubMed
Journal
Circulation
PubMed
Year
2014
PubMed
Publication types
Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
397
iCite
Relative citation ratio, by iCite
11.9
iCite
Revised in PubMed
2022-03-18
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morice MCMarie-Claude
2Serruys PWPatrick W
3Kappetein APA Pieter
4Feldman TETed E
5Ståhle EElisabeth
6Colombo AAntonio
7Mack MJMichael J
8Holmes DRDavid R
9Choi JWJames W
10Ruzyllo WWitold
11Religa GGrzegorz
12Huang JJian
13Roy KKristine
14Dawkins KDKeith D
15Mohr FFriedrich

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary Artery BypassMajor topic
Coronary Artery DiseaseMajor topic
Drug-Eluting StentsMajor topic
PaclitaxelMajor topic
Percutaneous Coronary InterventionMajor topic
Adult
Female
Follow-Up Studies
Humans
Incidence
Male
Risk Factors
Treatment Outcome
Tubulin Modulators

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00114972SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed ArteriesDerived from the trialYesClinicalTrials.gov
NCT03417050Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended SurvivalBackgroundClinicalTrials.gov
NCT05258318Double Rewire Versus Double Kissing Crush Stenting Technique in Left Main Bifurcation LesionsBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in24755917Coronary artery disease: Similar 5-year outcomes with CABG surgery or PCI for left main disease.https://conductscience.org/library/papers/24755917

Source PubMed

Download CSV of comments and corrections

Cited by158

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 397 citations.

PMIDTitleJournalYearIn PapersSource
42501240Impact of stent size selection during a single stenting with kissing balloon inflation for left main bifurcation lesions.Cardiovasc Interv Ther2026https://conductscience.org/library/papers/42501240PubMed
42438235Korean Society of Interventional Cardiology Expert Consensus for the Management of Chronic Coronary Syndrome: Part 2.Korean Circ J2026https://conductscience.org/library/papers/42438235PubMed
42368217Protected percutaneous coronary intervention of complex distal left main disease with Impella CP™ support.Eur Heart J Suppl2026https://conductscience.org/library/papers/42368217PubMed
42239549Middle East Bifurcation Club Consensus Document on Percutaneous Revascularization of Bifurcation Lesions in Association with the National Heart Center - Saudi Health Council.Saudi Med J2026https://conductscience.org/library/papers/42239549PubMed
41714707Invasive and medical management approaches to non-acute myocardial ischaemic syndromes.Nat Rev Cardiol2026https://conductscience.org/library/papers/41714707PubMed
41548856Avenues for optimization of cardiac therapeutics by minimally invasive delivery.Acta Biomater2026https://conductscience.org/library/papers/41548856PubMed
41449451Total coronary revascularization with anterior thoracotomy: it's not just about sternotomy.J Cardiothorac Surg2025https://conductscience.org/library/papers/41449451PubMed
41294178Guideline for Chronic Coronary Syndrome - 2025.Arq Bras Cardiol2025https://conductscience.org/library/papers/41294178PubMed
41184891Recent insights into the pathophysiology and implications for surgery in atherosclerosis.J Cardiothorac Surg2025https://conductscience.org/library/papers/41184891PubMed
41114310Clinical outcomes of double kissing crush or double kissing culotte technique in left main bifurcation lesions: the MAIN-ROUTE registry.Postepy Kardiol Interwencyjnej2025https://conductscience.org/library/papers/41114310PubMed
40924282Outcomes after percutaneous coronary intervention or coronary artery bypass grafting in patient with left main coronary artery disease: the TOkai LEft main RevAscularizatioN sTrategy (TOLERANT) study.Cardiovasc Interv Ther2026https://conductscience.org/library/papers/40924282PubMed
40794424The role of microparticles in oxidative stress and inflammation in patients with vascular intimal hyperplasia.J Int Med Res2025https://conductscience.org/library/papers/40794424PubMed
40710433Long-Term Outcome of Unprotected Left Main Percutaneous Coronary Interventions-An 8-Year Single-Tertiary-Care-Center Experience.J Pers Med2025https://conductscience.org/library/papers/40710433PubMed
40476636Stenting strategy and imaging use in left main percutaneous coronary intervention: insights from a 15-year registry.Future Cardiol2025https://conductscience.org/library/papers/40476636PubMed
40422950Percutaneous Coronary Intervention for Left Main Disease in High Bleeding Risk: Outcomes from a Subanalysis of the Delta 2 Registry.J Cardiovasc Dev Dis2025https://conductscience.org/library/papers/40422950PubMed
40004691The European Society of Cardiology 2024 Guidelines on Chronic Coronary Syndromes: A Critical Appraisal.J Clin Med2025https://conductscience.org/library/papers/40004691PubMed
39860334Complex Left Main Trifurcation: A Case Study of Successful Treatment.J Clin Med2025https://conductscience.org/library/papers/39860334PubMed
39493943Left Main Percutaneous Coronary Revascularization.US Cardiol2023https://conductscience.org/library/papers/39493943PubMed
39431313Prognostic value of pan immune-inflammation value in patients undergoing unprotected left main coronary artery stenting.Biomark Med2024https://conductscience.org/library/papers/39431313PubMed
39077332Left Main Coronary Artery Disease: A Contemporary Review of Diagnosis and Management.Rev Cardiovasc Med2024https://conductscience.org/library/papers/39077332PubMed

See all 158 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24700706

GET https://conductscience.org/api/papers/v1/24700706/cited_by?page=2